New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
09:18 EDTYONG, XOMA, AVAV, VEEV, NAVB, SWHC, NLSN, THRM, USU, IMRS, CSIQOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Smith & Wesson (SWHC), up 10%... AeroVironment (AVAV), up 7%... Gentherm (THRM), up 4%... Veeva (VEEV), up 5%. ALSO HIGHER: Dara (DARA), up 19% after signing agreement with WellCare (WCG) for Soltamox formulary status... Navidea (NAVB), up 3.7% after announcing FDA accepts sNDA to further expand Lymphoseek labeling. DOWN AFTER EARNINGS: Canadian Solar (CSIQ), down 5.4%... IMRIS (IMRS), down 3%. ALSO LOWER: XOMA (XOMA), down 21% after Phase II trial failure of gevokizumab in Erosive Osteoarthritis of the Hand... USEC (USU), down 29% after implementing financial restructuring plan under Chapter 11... Yongye (YONG), down 13% after announcing going private proposal not approved by stockholders...Nielsen (NLSN), down 2% after 30M share spot secondary offering of stock priced at $46.45.
News For SWHC;XOMA;USU;NAVB;YONG;THRM;VEEV;CSIQ;NLSN;AVAV;IMRS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 17, 2014
07:06 EDTCSIQCanadian Solar achieves PV module qualification with Sunrun
Canadian Solar announced that Sunrun, one of the largest dedicated residential solar companies in the United States, approved Canadian Solar as its qualified vendor.
November 14, 2014
06:43 EDTNLSNViacom CEO: Nielsen's ratings haven't kept up with trends, NY Times says
Subscribe for More Information
November 13, 2014
11:16 EDTCSIQCanadian Solar at a key technical juncture, levels to watch
Share price has continued to fall since earnings, with price last at $26.34. In a note from a few sessions ago we mentioned that there was a large potential head and shoulders pattern with a neckline at the $26 area. The behavior of the shares now may be either to trigger that pattern by continuing to fall below $26, or, to bounce thereby thwarting the pattern. A move below $26 would have the pattern become active, with downside potential over time to the $14 area. A bounce from these levels that sustains above $26 would void the pattern through time decay, price, or a combination of both.
09:14 EDTCSIQCanadian Solar should be bought opportunistically on weakness, says Roth Capital
Subscribe for More Information
08:43 EDTCSIQCanadian Solar should be bought on sell-off, says Canaccord
Canaccord reiterated its Buy rating on Canadian Solar following the sell-off after what it believes were solid Q3 results from the company. The firm feels the entire solar group is detached from fundamentals on concerns of cheap energy, but also believes investors were disappointed when the company did not provide details of a YieldCo set-up. Canaccord sees a growing pipeline and continued significant volume for Canadian Solar, but lowers its price target to $46 from $48.
November 12, 2014
11:40 EDTCSIQCanadian Solar sell-off unjustified on solid Q3 results, says JPMorgan
Subscribe for More Information
10:09 EDTCSIQCanadian Solar falls after results, potential bearish pattern forming
Subscribe for More Information
09:37 EDTCSIQActive equity options trading
Active equity options trading according to Track Data: AAPL CLSN TWTR BABA NFLX TSLA AMZN CSIQ C
09:21 EDTCSIQOn The Fly: Pre-market Movers
Subscribe for More Information
08:19 EDTNLSNJPMorgan to hold a conference
Subscribe for More Information
06:35 EDTCSIQU.S., China reach carbon emissions deal, NY Times says
Subscribe for More Information
06:00 EDTCSIQCanadian Solar raises FY14 revenue view to $2.93B-$2.98B from $2.7B-$2.9B
Consensus $2.83B. Raises FY14 annual module shipment guidance to 810 MW-860 MW.
05:58 EDTCSIQCanadian Solar sees Q4 revenue $925M-$975M, consensus $977.43M
Subscribe for More Information
05:57 EDTCSIQCanadian Solar reports Q3 EPS $1.75, consensus $1.16
Subscribe for More Information
November 11, 2014
15:32 EDTCSIQCanadian Solar November weekly 31.5 straddle priced for 12% move into Q3
Subscribe for More Information
07:31 EDTNAVBNavidea receives $1.1M PDUFA filing free refund for award of orphan drug status
Navidea Biopharmaceuticals announced it has received a $1.1M refund of the previously paid Prescription Drug User Fee Act filing fee related to the granting of orphan drug status of Lymphoseek injection in head and neck cancers. Lymphoseek was granted Orphan Drug Designation by the FDA in September 2014 for use in sentinel lymph node detection in patients with cancer of the head and neck. Additionally, Platinum Partners, Navidea’s major investor, reaffirmed its support of the company through the remaining $31.8M available under the previously announced line of credit. “We believe we have sufficient capital resources to attain our immediate goals and realize the full commercial potential for Lymphoseek,” said Rick Gonzalez, Navidea CEO. “We are in a position to manage our available cash with our expected growth in revenue and gross profit, our ability to further reduce our operating costs and, if needed, our access to capital under the line of credit from Platinum Partners.”
November 10, 2014
13:50 EDTCSIQCanadian Solar volatility elevated into Q3 and outlook
Subscribe for More Information
10:04 EDTXOMAOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Abercrombie & Fitch (ANF) downgraded at Oppenheimer... American Eagle (AEO) downgraded to Neutral from Buy at B. Riley... BP (BP) downgraded to Neutral from Overweight at JPMorgan... Callon Petroleum (CPE) downgraded to Neutral from Buy at SunTrust... EP Energy (EPE) downgraded to Hold from Buy at Deutsche Bank... Eaton Vance (EV) downgraded at Sterne Agee... Ecopetrol (EC) downgraded to Underperform from Sector Perform at RBC Capital... General Mills (GIS) downgraded to Sector Perform from Outperform at RBC Capital... Genworth (GNW) downgraded to Market Perform from Outperform at Keefe Bruyette... MasTec (MTZ) downgraded to Hold from Buy at BB&T... Ocean Rig UDW (ORIG) downgraded to Neutral from Buy at Guggenheim... Performant Financial (PFMT) downgraded at Morgan Stanley... Petrobras (PBR) downgraded to Market Perform from Outperform at Cowen... R.R. Donnelley (RRD) downgraded to Hold from Buy at Benchmark Co.... Rex Energy (REXX) downgraded to Market Perform from Outperform at BMO Capital... Salix (SLXP) downgraded to Neutral from Buy at Mizuho... Siemens (SIEGY) downgraded to Neutral from Overweight at JPMorgan... Solazyme (SZYM) downgraded to Equal Weight from Overweight at Morgan Stanley... Stonegate Mortgage (SGM) downgraded to Market Perform at FBR Capital... Syngenta (SYT) downgraded to Neutral from Overweight at HSBC... ViaSat (VSAT) downgraded to Hold from Buy at Needham... Vistaprint (VPRT) downgraded to Neutral from Buy at SunTrust... Walter Investment (WAC) downgraded at Sterne Agee... WesBanco (WSBC) downgraded to Market Perform from Outperform at Keefe Bruyette... Whiting USA Trust II (WHZ) downgraded to Underperform at Raymond James... Wipro (WIT) downgraded to Sell from Buy at UBS... XOMA (XOMA) downgraded to Neutral from Buy at Ladenburg... Yanzhou Coal (YZC) downgraded to Sell from Hold at Deutsche Bank.
07:12 EDTCSIQCanadian Solar to supply 4 MW energy storage solution to support Ontario grid
Subscribe for More Information
07:03 EDTXOMAXOMA downgraded to Neutral from Buy at Ladenburg
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use